Chromos Molecular Systems Inc. has announced that it has expanded the scope of its collaboration agreement with Pfizer. Under the expanded agreement, Chromos will use its ACE System to develop a cell ...

SAFC Biosciences, a member of the Sigma-Aldrich Group and Chromos Molecular Systems Inc. have entered into a non-exclusive co-marketing arrangement whereby SAFC Biosciences and Chromos will jointly ...

For Royal College of Art design students Chris Glaister, Afshin Mehin and Tomas Rosen, the problem with concrete is once you put it down you can’t change it, and people have to just get used to it. So ...

Chromos Molecular Systems, a small Canadian drug developer, says it is laying off about half of its 25 workers and is preparing to file for bankruptcy. In a statement released on Thursday, the company ...

MUMBAI, July 19 (Reuters) - Drug maker Glenmark Pharmaceuticals Ltd. said on Thursday it bought two new biological entities from Canada's Chromos Molecular Systems Inc. to strengthen its biological ...

CHR-1103 is an anti-inflammatory agent and CHR-1201 is an antithrombolytic. Glenmark Pharmaceuticals completed the purchase of two NBEs from Chromos Molecular Systems. CHR-1103 and CHR-1201 are ...

No articles found. Chromos Molecular Systems Inc. did not contribute to any primary research papers from Nature Index journals in the current 12 month window.